Randomized cross-over study of adverse reactions and cost implications of intravenous push compared with infusion of iron dextran in hemodialysis patients
- 31 October 1996
- journal article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 28 (4) , 523-528
- https://doi.org/10.1016/s0272-6386(96)90462-x
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Removal of iron dextran by hemodialysis: An in vitro studyAmerican Journal of Kidney Diseases, 1995
- Iron Management During Treatment with Recombinant Human Erythropoietin in Chronic Renal FailureThe Journal of Clinical Pharmacology, 1993
- RACTICAL GUIDELINES FOR DRUG THERAPY IN DIALYSIS George R. Aronoff, Series Editor: Iron Dextran in Chronic Renal FailureSeminars in Dialysis, 1991